Isoniazid-related hepatic failure in children: A survey of liver transplantation centers

Transplantation

Volumn 84, Issue 2, 2007, Pages 173-179

  Wu, Steven S ^a   Chao, Catherine S ^a   Vargas, Jorge H ^a   Sharp, Harvey L ^b   Martín, Martín G ^a   McDiarmid, Sue V ^a   Sinatra, Frank R ^c   Ament, Marvin E ^a  

^a MATTEL CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Bacille Calmette Gu rain; Hepatotoxicity; Isoniazid; Liver failure; Pediatrics; Transplantation

Indexed keywords

ISONIAZID;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONVALESCENCE; FEMALE; HEALTH SURVEY; HEPATITIS; HUMAN; INCIDENCE; LIVER FAILURE; LIVER TOXICITY; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; TUBERCULOSIS; UNITED STATES;

ADOLESCENT; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, PEDIATRIC; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; ISONIAZID; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUBERCULOSIS; UNITED STATES;

EID: 34547627278     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000269104.22502.d2     Document Type: Article

References (48)

1. Abernathy RS. Tuberculosis: An update. Pediatr Rev 1997; 18: 50.
2. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: Five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis. Bull World Health Organ 1982; 60: 555.
3. Pediatric Tuberculosis Collaborative Group. Targeted tuberculin skin testing and treatment of latent tuberculosis infection in children and adolescents. Pediatrics 2004; 114: 1175.
4. Mitchell JR, Zimmerman HJ, Ishak KG, et al. Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. Ann Intern Med 1976; 84: 181.
5. Saukkonen JJ, Cohn DL, Jasmer RM, et al. An official ATS statement: Hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med 2006; 174: 935.
6. Beaudry PH, Brickman HF, Wise MB, MacDougall D. Liver enzyme disturbances during isoniazid chemoprophylaxis in children. Am Rev Respir Dis 1974; 110: 581.
7. Spyridis P, Sinaniotis C, Papadea I, et al. Isoniazid liver injury during chemoprophylaxis in children. Arch Dis Child 1979; 54: 65.
8. Litt IF, Cohen MI, McNamara H. Isoniazid hepatitis in adolescents. J Pediatr 1976; 89: 133.
9. Rapp RS, Campbell RW, Howell JC, Kendig EL Jr. Isoniazid hepatotoxicity in children. Am Rev Respir Dis 1978; 118: 794.
10. Bailey WC, Taylor SL, Dascomb HE, et al. Disturbed hepatic function during isoniazid chemoprophylaxis. Monitoring the hepatic function of 427 hospital employees receiving isoniazid chemoprophylaxis for tuberculosis. Am Rev Respir Dis 1973; 107: 523.
11. Byrd RB, Horn BR, Solomon DA, Griggs GA. Toxic effects of isoniazid in tuberculosis chemoprophylaxis. Role of biochemical monitoring in 1,000 patients. JAMA 1979; 241: 1239.
12. Nolan CM, Goldberg SV, Buskin SE. Hepatotoxicity associated with isoniazid preventive therapy: A 7-year survey from a public health tuberculosis clinic. JAMA 1999; 281: 1014.
13. Kopanoff DE, Snider DE Jr, Caras GJ. Isoniazid-related hepatitis: A U.S. Public Health Service cooperative surveillance study. Am Rev Respir Dis 1978; 117: 991.
14. Garibaldi RA, Drusin RE, Ferebee SH, Gregg MB. Isoniazid-associated hepatitis. Report of an outbreak. Am Rev Respir Dis 1972; 106: 357.
15. Aziz H, Shubair M, Debari VA, et al. Assessment of age-related isoniazid hepatotoxicity during treatment of latent tuberculosis infection. Curr Med Res Opin 2006; 22: 217.
16. Nakajo MM, Rao M, Steiner P. Incidence of hepatotoxicity in children receiving isoniazid chemoprophylaxis. Pediatr Infect Dis J 1989; 8: 649.
17. Nemir RL, O'Hare D. Tuberculosis in children 10 years of age and younger: Three decades of experience during the chemotherapeutic era. Pediatrics 1991; 88: 236.
18. Palusci VJ, O'Hare D, Lawrence RM. Hepatotoxicity and transaminase measurement during isoniazid chemoprophylaxis in children. Pediatr Infect Dis J 1995; 14: 144.
19. Millard PS, Wilcosky TC, Reade-Christopher SJ, Weber DJ. Isoniazid-related fatal hepatitis. West J Med 1996; 164: 486.
20. Snider DE Jr, Caras GJ. Isoniazid-associated hepatitis deaths: A review of available information. Am Rev Respir Dis 1992; 145: 494.
21. Vanderhoof JA, Ament ME. Fatal hepatic n?crosis due to isoniazid chemoprophylaxis in a 15-year-old girl. J Pediatr 1976; 88: 867.
22. Gal AA, Klatt EC. Fatal isoniazid hepatitis in a child. Pediatr Infect Dis 1986; 5: 490.
23. Moulding TS, Redeker AG, Kanel GC. Twenty isoniazid-associated deaths in one state. Am Rev Respir Dis 1989; 140: 700.
24. Farrell FJ, Keeffe EB, Man KM, et al. Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation. Dig Dis Sci 1994; 39: 2255.
25. Meyers BR, Halpern M, Sheiner P, et al. Acute hepatic failure in seven patients after prophylaxis and therapy with antituberculous agents. Successful treatment with orthotopic liver transplantation. Transplantation 1994; 58: 372.
26. Cillo U, Bassanello M, Vitale A, et al. Isoniazid-related fulminant hepatic failure in a child: Assessment of the native liver's early regeneration after auxiliary partial orthotopic liver transplantation. Transpl Int 2005; 17: 713.
27. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161: S221.
28. Cahen DL, van Leeuwen DJ, ten Kate FJ, et al. Do serum ALAT values reflect the inflammatory activity in the liver of patients with chronic viral hepatitis? Liver 1996; 16: 105.
29. Hasagawa T, Reyes J, Nour B, et al. Successful liver transplantation for isoniazid-induced hepatic failure-a case report. Transplantation 1994; 57: 1274.
30. Israel HL, Gottlieb JE, Maddrey WC. Perspective: Preventive isoniazid therapy and the liver. Chest 1992; 101: 1298.
31. Tsagaropoulou-Stinga H, Mataki-Emmanouilidou T, Karida-Kavalioti S, Manios S. Hepatotoxic reactions in children with severe tuberculosis treated with isoniazid-rifampin. Pediatr Infect Dis 1985; 4: 270.
32. Crippin JS. Acetaminophen hepatotoxicity: potentiation by isoniazid. Am J Gastroenterol 1993; 88: 590.
33. Nolan CM, Sandblom RE, Thummel KE, et al. Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis. Chest 1994; 105: 408.
34. O'Brien RJ, Long MW, Cross FS, et al. Hepatotoxicity from isoniazid and rifampin among children treated for tuberculosis. Pediatrics 1983; 72: 491.
35. Pessayre D, Bentata M, Degott C, et al. Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction. Gastroenterology 1977; 72: 284.
36. Durand F, Jebrak G, Pessayre D, et al. Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver status. Drug Saf 1996; 15: 394.
37. Schaberg T, Rebhan K, Lode H. Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis. Eur Respir J 1996; 9: 2026.
38. Patel PA, Voigt MD. Prevalence and interaction of hepatitis B and latent tuberculosis in Vietnamese immigrants to the United States. Am J Gastroenterol 2002; 97: 1198.
39. Wu JC, Lee SD, Yeh PF, et al. Isoniazid-rifampin-induced hepatitis in hepatitis B carriers. Gastroenterology 1990; 98: 502.
40. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000; 49: 1.
41. Gendrel D, Nardou M, Mouba JF, et al. [Hepatotoxicity of the combination of isoniazid-rifampicin in African children. Role of malnutrition and HB virus.] Arch Fr Pediatr 1989; 46: 645.
42. Dart RC, Erdman AR, Olson KR, et al. Acetaminophen poisoning: An evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila) 2006; 44: 1.
43. Bernstein BH, Singsen BH, King KK, Hanson V. Aspirin-induced hepatotoxicity and its effect on juvenile rheumatoid arthritis. Am J Dis Child 1977; 131: 659.
44. Bjornsson E, Lindberg J, Olsson R. Liver reactions to oral low-dose tetracyclines. Scand J Gastroenterol 1997; 32: 390.
45. Black M, Mitchell JR, Zimmerman HJ, et al. Isoniazid-associated hepatitis in 114 patients. Gastroenterology 1975; 69: 289.
46. Wang L, Turner MO, Elwood RK, et al. A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 2002; 57: 804.
47. Dossing M, Wilcke JT, Askgaard DS, Nybo B. Liver injury during antituberculosis treatment: an 11-year study. Tuber Lung Dis 1996; 77: 335.
48. Fountain FF, Tolley E, Chrisman CR, Self TH. Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: A 7-year evaluation from a public health tuberculosis clinic. Chest 2005; 128: 116.